Bob Lutz
Chief Scientific Officer Iksuda Therapeutics
Seminars
Thursday 10th September 2026
Reflecting on the First Attempts with Novel Payloads, & What we are Doing Differently Now
8:45 am
- What is the path to success for novel payloads, including how to navigate early assessment of payload platforms?
- What are the challenges when doing something different and how are we decreasing risk when translating preclinical optimism into clinical success?
- Discussing the panellists’ approach to business development. What would a win/ win business deal look like that focuses on payloads?
Thursday 10th September 2026
Finding a Gap: Achieving Good Response Rates in Difficult Tumor Types
3:00 pm
- How do established payloads compare in their ability to drive meaningful clinical responses?
- Have historically pursued targets lacked sufficient expression or accessibility to enable effective tumor penetration?
- What role can mechanisms play in increasing efficacy?
